The study authors examined patient records for all patients who underwent surgery for metastatic spinal disease at one of four academic medical center in New England from 2007 to 2013. There were 318 patients who were examined in the study. They examined the 30-day and 90-day survival rate.
Here are five key findings:
1. The type of cancer didn’t influence the odds of 30-day survival.
2. Nutritional status and ambulatory capacity increased the 30-day survival rate.
3. The patients with lung cancer decreased the 90-day survival rate odd after surgery.
4. Ambulatory function and nutritional status were significantly associated with improved 90-day survival rate.
5. The study authors concluded, “Improved nutritional status and ambulatory function may enhance postoperative survival among individuals who undergo surgical intervention for spinal metastases.”
More articles on spine surgery:
Does surgery for lumbar disc herniation return elite athletes to play? 4 key notes
Spinal fusion adds little benefit for lumbar stenosis—11 takeaways from 2 studies
Material matter: How value-based spine devices can help meet the triple-aim
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
